BOCH
IRON icon

Blue Owl Capital Holdings’s Disc Medicine IRON Stock Holding History

Blue Owl Capital Holdings’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-102,260
Closed -$6.76M – 82
2025
Q3 		$6.76M Sell
102,260
-20,000
-16% -$1.19M 2.1% 17
2025
Q2 		$6.47M Sell
122,260
-18,000
-13% -$845K 2.09% 14
2025
Q1 		$6.96M Buy
140,260
+20,000
+17% +$1.11M 2.25% 12
2024
Q4 		$7.62M Sell
120,260
-55,000
-31% -$3.18M 1.76% 15
2024
Q3 		$8.61M Sell
175,260
-40,000
-19% -$1.88M 1.66% 16
2024
Q2 		$9.7M Buy
215,260
+60,000
+39% +$2.04M 2.7% 13
2024
Q1 		$9.67M Buy
155,260
+15,000
+11% +$973K 1.93% 15
2023
Q4 		$8.1M Buy
+140,260
New +$7.18M 1.94% 14

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return